SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of 1Life Healthcare, Inc. (ONEM) and Encourages Stockholders to Contact the Firm

June 08, 2021 7:00 AM EDT | Source: Kaskela Law LLC

Philadelphia, Pennsylvania--(Newsfile Corp. - June 8, 2021) - Kaskela Law LLC announces that is investigating 1Life Healthcare, Inc. (One Medical) (NASDAQ: ONEM) on behalf of the Company's stockholders.

On June 7, 2021, One Medical announced that it had entered into an agreement to acquire Iora Health in an all-stock transaction valued at approximately $2.1 billion. Under the terms of the agreement, Iora Health shareholders will receive 56.1 million shares of One Medical common stock. Upon completion of the transaction, Iora Health shareholders are expected to own approximately 26.75% of the combined company.

The investigation seeks to determine whether One Medical's executive officers and directors violated the securities laws and/or breached their fiduciary duties in connection with the proposed merger with Iora, and whether One Medical stockholders are receiving all material information in connection with the proposed transaction.

One Medical stockholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 - 1585, or by email at skaskela@kaskelalaw.com or online at https://kaskelalaw.com/case/1life-healthcare-inc/, for additional information about this investigation and their legal rights and options with respect to this proposed transaction.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.

CONTACT:

D. Seamus Kaskela, Esq.
KASKELA LAW LLC
18 Campus Boulevard, Suite 100
Newtown Square, PA 19073
(484) 258 - 1585
(888) 715 - 1740
www.kaskelalaw.com
skaskela@kaskelalaw.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/86835

info